-
Getting Clinical Trials Back on Track
Sarah Harding
February 04, 2021
I think it is fair to say that R&D is the lifeblood of the pharma industry, and no drug discovery program can be completed without its clinical trials.
-
How to Evaluate the Safety of COVID-19 Vaccines, Such as Adverse Reactions, Preclinically?
PharmaSources/Shanghai Xiaoyaoshi
January 21, 2021
Vaccines have effectively controlled many infectious diseases, however, the adverse reactions following vaccination cannot be always avoided.
-
Chinese Vaccines Going Global amid Receipt of the COVID-19 Vaccines Worldwide
PharmaSources/Xiaoyaowan
February 08, 2021
The COVID-19 pandemic has circulated again recently in Europe and America, with the number of new confirmed cases hitting new highs in countries represented by the UK and the U.S., which has objectively put forward higher requirements for pandemic prevent
-
Remdesivir ineffective against COVID-19? Perhaps it is not taken the right way
PharmaSources/Shanghai Xiaoyaoshi
January 07, 2021
Remdesivir ineffective against COVID-19? Has a bleak prospect?! Perhaps it is not taken the right way.
-
A Smarter Pharma Industry: The Key to Addressing Challenges During the COVID-19 Pandemic
Sarah Harding
December 24, 2020
China has been viewed in recent years as a ‘rising star’ of the pharma industry. Notwithstanding political pressures – primarily from the US – founded on concerns over China’s growing dominance in the field.
-
PIONEER SPEED - Charming Fully Support All the Pharmaceutical Companies to Fight Against COVID-19
PharmaSources.com
December 24, 2020
The spread rapidly of COVID-19 across china at the end of 2019 has a huge impact on China's economy and people's livelihood.
-
Global Demand For COVID-19 Products Presents Huge Opportunities for the Biomanufacturing Sector
Sarah Harding
November 27, 2020
In 2020, as part of the fight against COVID-19, we have witnessed incredible collaborations between biotech, big pharma, academia and not-for-profit organizations, all working together to develop treatments and vaccines at record speed.
-
Discovering Biotechnology: Developments in COVID-19 Diagnostic tests
Deborah Seah
November 09, 2020
Diagnostic tests by definition are any method used to obtain information of a patient’s clinical condition for healthcare professionals to make an informed clinical decision.
-
Pharmaceutical News of August | PharmaSources.com: COVID-19
PharmaSources/Caicai
September 23, 2020
AstraZeneca announced the initiation of Phase III clinical trial for its adenovirus vector-based COVID-19 vaccine: AZD1222 in the U.S. on Aug. 31, which has a code of D8110C00001 and is funded by the Biomedical Advanced Research and Development Authority
-
Pharma Business Benefits from the Shift of Sales and Marketing to a More Digitally-driven Approach
Sarah Harding
August 24, 2020
The ongoing COVID-19 pandemic is continuing to have a significant impact on the way we do business. Pharma business may benefit from the shift of sales and marketing to a more digitally-driven approach.